Frontlight ResearchEarly access
Trial site
Clinical Trials Center of Middle Tennessee
- 4running trials
- 5closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Idiopathic pulmonary fibrosis5 trials
- COPD2 trials
- Bronchiectasis1 trial
- Cystic fibrosis1 trial
- Long COVID and ME/CFS1 trial
- Rheumatoid arthritis1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 27 trials
- Phase 32 trials
- Status
- Completed4 trials
- Active, not recruiting2 trials
- Enrolling by invitation1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA2 trials
- Avalyn Pharma Inc.1 trial
- Hoffmann-La Roche1 trial
- Kanecia Obie Zimmerman1 trial
- Pliant Therapeutics, Inc.1 trial
- and 3 more
Running trials
Recruiting
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
Active, not recruiting
Enrolling by invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
Active, not recruiting
LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bronchiectasis1 recruiting
- Cystic fibrosis1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
Closed trials
Completed
Terminated
Completed
Completed
Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis
Completed
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Site data: ClinicalTrials.govUpdated 12 Nov 2026